Mirae Asset Global Investments Co., Ltd. Xeris Biopharma Holdings, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 6,187 shares of XERS stock, worth $31,986. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,187
Previous 4,988
24.04%
Holding current value
$31,986
Previous $27,000
3.7%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding XERS
# of Institutions
205Shares Held
84.6MCall Options Held
132KPut Options Held
69.4K-
Black Rock Inc. New York, NY10.3MShares$53.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.11MShares$41.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.29MShares$22.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.41MShares$17.6 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$17.2 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $703M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...